| Identification | Back Directory | [Name]
TBOPP | [CAS]
1996629-79-8 | [Synonyms]
TBOPP
2(1H)-Pyridinone, 1-[2-oxo-2-[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]ethyl]-5-(1-pyrrolidinylsulfonyl)-
1-(2-Oxo-2-(3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)ethyl)-5-(pyrrolidin-1-ylsulfonyl)pyridin-2(1H)-one | [Molecular Formula]
C24H21F3N2O4S | [MDL Number]
MFCD32215320 | [MOL File]
1996629-79-8.mol | [Molecular Weight]
490.49 |
| Chemical Properties | Back Directory | [Boiling point ]
645.4±65.0 °C(Predicted) | [density ]
1.46±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 125 mg/mL (254.85 mM) | [form ]
Solid | [pka]
-2.46±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
1-(2-Oxo-2-(3''-(trifluoromethyl)-[1,1''-biphenyl]-4-yl)ethyl)-5-(pyrrolidin-1-ylsulfonyl)pyridin-2(1H)-one is a selective inhibitor of DOCK1 as a therapeutic approach to target cancer cell survival and invasion. |
|
|